Incremental costs of enrolling cancer patients in clinical trials: A population-based study

Journal of the National Cancer Institute

Volumn 91, Issue 10, 1999, Pages 847-853

  Wagner, Judith L ^a   Alberts, Steven R ^b   Sloan, Jeff A ^b   Cha, Steven ^b   Killian, Jill ^b   O'Cornell, Michael J ^b   Van Grevenhof, Priscilla ^b   Lindman, Jed ^c   Chute, Christopher G ^b  

^a Macroeconomic Analysis Division   (United States)

^b MAYO CLINIC   (United States)

^c WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; MANAGED CARE; MEDICARE; PATIENT CARE; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; SOCIOECONOMICS;

EID: 0033583765     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.10.847     Document Type: Article

References (17)

1. Mechanic R, Dobson A. The impact of managed care on clinical research: a preliminary investigation. Health Affairs 1996;15:72-88.
2. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
3. nd ed. Geneva (Switzerland): WHO; 1990.
4. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
5. Lipscomb J, Ancukiewicz M, Parmigiana G, Hasselblad V, Samsa G, Matchar DB. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998;18(2 Suppl):S39-56.
6. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-9.
7. Finkler SA. The distinction between costs and charges. In: Finkler SA, editor. Issues in cost accounting for health care organizations. Gaithersburg (MD): Aspen Publishers; 1994. p. 81-93.
8. Kahn AE. The economics of regulation: volume 1, principles and institutions. New York (NY): John Wiley & Sons; 1970.
9. Prospective Payment Assessment Commission. Medicare and the American health care system: report to Congress. Washington (DC): Prospective Payment Assessment Commission; 1997.
10. Gold MR, Siegel J, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press; 1996.
11. Etzioni R, Urban N, Baker M. Estimating the costs attributable to a disease with application to ovarian cancer. J Clin Epidemiol 1996;49:95-103.
12. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53:419-34.
13. Hallstrom AP, Sullivan SD. On estimating costs for economic evaluation in failure time studies. Med Care 1998;36:433-6.
14. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale (NJ): Laurence Erlbaum & Associates; 1988.
15. Efron B. The jackknife, the bootstrap, and other resampling plans. Philadelphia (PA): Society for Industrial and Applied Mathematics; 1982.
16. Fowles JB, Weiner JP, Knutson D, Fowler E, Tucker AM, Ireland M. Taking health status into account when setting capitation rates: a comparison of risk-adjustment methods. JAMA 1996;276:1316-21.
17. Daniels N, Sabin JE. Last chance therapies and managed care. Pluralism, fair procedures, and legitimacy. Hastings Cent Rep 1998;28:27-41.